GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 25 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -54.2% | 30,080 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | -31.4% | 30,080 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | +45.8% | 30,080 | 0.0% | 0.00% | – |
| Q4 2018 | $24,000 | -61.3% | 30,080 | 0.0% | 0.00% | – |
| Q3 2018 | $62,000 | -79.8% | 30,080 | 0.0% | 0.00% | – |
| Q2 2018 | $307,000 | +56.6% | 30,080 | 0.0% | 0.00% | – |
| Q1 2018 | $196,000 | +34.2% | 30,080 | +63.7% | 0.00% | – |
| Q4 2017 | $146,000 | +43.1% | 18,372 | +70.6% | 0.00% | – |
| Q3 2017 | $102,000 | – | 10,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 869,538 | $1,000,000 | 0.58% |
| VHCP Management II, LLC | 513,752 | $591,000 | 0.17% |
| Exchange Capital Management, Inc. | 522,481 | $601,000 | 0.17% |
| GM Advisory Group, LLC | 43,335 | $50,000 | 0.02% |
| Truvestments Capital LLC | 4,926 | $6,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 173,044 | $199,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 10,000 | $12,000 | 0.00% |
| ERTS Wealth Advisors, LLC | 4,112 | $3,000 | 0.00% |
| SEGALL BRYANT & HAMILL, LLC | 30,000 | $35,000 | 0.00% |
| Advisory Services Network, LLC | 12,910 | $15,000 | 0.00% |